Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9273302B2 · kind B2 · utility
7Cited by
49References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 7, 2014 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Aug 7, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.